Literature DB >> 23386604

Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.

Dany Fillion1, Jérôme Cabana, Gaétan Guillemette, Richard Leduc, Pierre Lavigne, Emanuel Escher.   

Abstract

Breakthroughs in G protein-coupled receptor structure determination based on crystallography have been mainly obtained from receptors occupied in their transmembrane domain core by low molecular weight ligands, and we have only recently begun to elucidate how the extracellular surface of G protein-coupled receptors (GPCRs) allows for the binding of larger peptide molecules. In the present study, we used a unique chemoselective photoaffinity labeling strategy, the methionine proximity assay, to directly identify at physiological conditions a total of 38 discrete ligand/receptor contact residues that form the extracellular peptide-binding site of an activated GPCR, the angiotensin II type 1 receptor. This experimental data set was used in homology modeling to guide the positioning of the angiotensin II (AngII) peptide within several GPCR crystal structure templates. We found that the CXC chemokine receptor type 4 accommodated the results better than the other templates evaluated; ligand/receptor contact residues were spatially grouped into defined interaction clusters with AngII. In the resulting receptor structure, a β-hairpin fold in extracellular loop 2 in conjunction with two extracellular disulfide bridges appeared to open and shape the entrance of the ligand-binding site. The bound AngII adopted a somewhat vertical binding mode, allowing concomitant contacts across the extracellular surface and deep within the transmembrane domain core of the receptor. We propose that such a dualistic nature of GPCR interaction could be well suited for diffusible linear peptide ligands and a common feature of other peptidergic class A GPCRs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386604      PMCID: PMC3605637          DOI: 10.1074/jbc.M112.442053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  The active and the inactive form of the hAT1 receptor have an identical ligand-binding environment: an MPA study on a constitutively active angiotensin II receptor mutant.

Authors:  Martin Clément; Caroline Chamberland; Jacqueline Pérodin; Richard Leduc; Gaétan Guillemette; Emanuel Escher
Journal:  J Recept Signal Transduct Res       Date:  2006       Impact factor: 2.092

Review 2.  Molecular mechanism of 7TM receptor activation--a global toggle switch model.

Authors:  Thue W Schwartz; Thomas M Frimurer; Birgitte Holst; Mette M Rosenkilde; Christian E Elling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

3.  Role of N-glycosylation in the expression and functional properties of human AT1 receptor.

Authors:  P M Lanctôt; P C Leclerc; E Escher; R Leduc; G Guillemette
Journal:  Biochemistry       Date:  1999-07-06       Impact factor: 3.162

4.  Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.

Authors:  S A Laporte; A A Boucard; G Servant; G Guillemette; R Leduc; E Escher
Journal:  Mol Endocrinol       Date:  1999-04

5.  Identification of a conserved switch residue responsible for selective constitutive activation of the beta2-adrenergic receptor.

Authors:  M J Zuscik; J E Porter; R Gaivin; D M Perez
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

6.  Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay.

Authors:  Martin Clément; Stéphane S Martin; Marie-Eve Beaulieu; Caroline Chamberland; Pierre Lavigne; Richard Leduc; Gaétan Guillemette; Emanuel Escher
Journal:  J Biol Chem       Date:  2005-05-12       Impact factor: 5.157

7.  The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism.

Authors:  Y H Feng; K Noda; Y Saad; X P Liu; A Husain; S S Karnik
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

8.  Enhancement of cyanogen bromide cleavage yields for methionyl-serine and methionyl-threonine peptide bonds.

Authors:  R Kaiser; L Metzka
Journal:  Anal Biochem       Date:  1999-01-01       Impact factor: 3.365

9.  Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.

Authors:  Stéphane S Martin; Antony A Boucard; Martin Clément; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

10.  LOMETS: a local meta-threading-server for protein structure prediction.

Authors:  Sitao Wu; Yang Zhang
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

View more
  16 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.

Authors:  Jérôme Cabana; Brian Holleran; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

3.  Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.

Authors:  Laurence Gagnon; Yubo Cao; Aaron Cho; Dana Sedki; Thomas Huber; Thomas P Sakmar; Stéphane A Laporte
Journal:  J Biol Chem       Date:  2019-09-17       Impact factor: 5.157

4.  Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.

Authors:  Laura M Wingler; Conor McMahon; Dean P Staus; Robert J Lefkowitz; Andrew C Kruse
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 5.  Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.

Authors:  Takanobu Takezako; Hamiyet Unal; Sadashiva S Karnik; Koichi Node
Journal:  Pharmacol Res       Date:  2017-06-23       Impact factor: 7.658

6.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

Review 7.  Novel molecular angiotensin converting enzyme and angiotensin receptor imaging techniques.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

Review 8.  The importance of non-HLA antibodies in transplantation.

Authors:  Qiuheng Zhang; Elaine F Reed
Journal:  Nat Rev Nephrol       Date:  2016-06-27       Impact factor: 28.314

9.  Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type 1 Receptor.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2017-12-27       Impact factor: 4.956

Review 10.  Structural insights into ligand recognition and activation of angiotensin receptors.

Authors:  Haitao Zhang; Aleksandra Luginina; Alexey Mishin; Mithu Baidya; Arun K Shukla; Vadim Cherezov
Journal:  Trends Pharmacol Sci       Date:  2021-05-10       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.